{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:21:34Z","timestamp":1785010894454,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772797, 81472462"],"award-info":[{"award-number":["81772797, 81472462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support","award":["20172007"],"award-info":[{"award-number":["20172007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12957-019-1582-z","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T09:05:11Z","timestamp":1550653511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era"],"prefix":"10.1186","volume":"17","author":[{"given":"Yue","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-9756","authenticated-orcid":false,"given":"Xiaosong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"1582_CR1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","volume":"28","author":"G Curigliano","year":"2017","unstructured":"Curigliano G, Burstein HJ, E PW, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017;28:1700\u201312.","journal-title":"Ann Oncol"},{"key":"1582_CR2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thurlimann B, Senn HJ. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26:1533\u201346.","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"1582_CR3","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, Zackrisson S, Cardoso F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8\u201330.","journal-title":"Ann Oncol"},{"key":"1582_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bjs.9663","volume":"102","author":"BJ Wely van","year":"2015","unstructured":"van Wely BJ, de Wilt JH, Francissen C, Teerenstra S, Strobbe LJ. Meta-analysis of ultrasound-guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer. Br J Surg. 2015;102:159\u201368.","journal-title":"Br J Surg"},{"key":"1582_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/SLA.0b013e31821f1564","volume":"254","author":"N Houssami","year":"2011","unstructured":"Houssami N, Ciatto S, Turner RM, Cody HS 3rd, Macaskill P. Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg. 2011;254:243\u201351.","journal-title":"Ann Surg"},{"key":"1582_CR6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.amjsurg.2011.10.016","volume":"204","author":"H Caretta-Weyer","year":"2012","unstructured":"Caretta-Weyer H, Sisney GA, Beckman C, Burnside ES, Salkowsi LR, Strigel RM, Wilke LG, Neuman HB. Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer. Am J Surg. 2012;204:308\u201314.","journal-title":"Am J Surg"},{"key":"1582_CR7","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1245\/s10434-017-5798-2","volume":"24","author":"Y Liang","year":"2017","unstructured":"Liang Y, Chen X, Zhan W, Garfield DH, Wu J, Huang O, Li Y, Zhu L, Chen W, Shen K. Can clinically node-negative breast cancer patients with suspicious axillary lymph nodes at ultrasound but negative fine-needle aspiration be approached as having node-negative disease? Ann Surg Oncol. 2017;24:1874\u201380.","journal-title":"Ann Surg Oncol"},{"key":"1582_CR8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA."},{"key":"1582_CR9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264:413\u201320.","journal-title":"Ann Surg"},{"key":"1582_CR10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918\u201326.","journal-title":"JAMA."},{"key":"1582_CR11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Temin S, Edge SB, Newman LA, Turner RR, Weaver DL, Benson AB 3rd, Bosserman LD, Burstein HJ, Cody H 3rd, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365\u201383.","journal-title":"J Clin Oncol"},{"key":"1582_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1245\/s10434-011-1823-z","volume":"19","author":"WP Weber","year":"2012","unstructured":"Weber WP, Barry M, Stempel MM, Junqueira MJ, Eaton AA, Patil SM, Morrow M, Cody HS 3rd. A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol. 2012;19:225\u201332.","journal-title":"Ann Surg Oncol"},{"key":"1582_CR13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7863\/ultra.15.06019","volume":"35","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhou W, Zhou JQ, Fei XC, Ye TJ, Huang O, Chen XS, Zhan WW. Axillary staging of early-stage invasive breast cancer by ultrasound-guided fine-needle aspiration cytology: which ultrasound criteria for classifying abnormal lymph nodes should be adopted in the post-ACOSOG Z0011 trial era? J Ultrasound Med. 2016;35:885\u201393.","journal-title":"J Ultrasound Med"},{"key":"1582_CR14","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al. American Society of Clinical Oncology\/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784\u201395.","journal-title":"J Clin Oncol"},{"key":"1582_CR15","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997\u20134013.","journal-title":"J Clin Oncol"},{"key":"1582_CR16","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206\u201323.","journal-title":"Ann Oncol"},{"key":"1582_CR17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-015-3388-1","volume":"151","author":"G Farshid","year":"2015","unstructured":"Farshid G, Kollias J, Grantley Gill P. The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era. Breast Cancer Res Treat. 2015;151:347\u201355.","journal-title":"Breast Cancer Res Treat"},{"key":"1582_CR18","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1007\/s00330-015-3683-6","volume":"25","author":"TP Farrell","year":"2015","unstructured":"Farrell TP, Adams NC, Stenson M, Carroll PA, Griffin M, Connolly EM, O'Keeffe SA. The Z0011 trial: is this the end of axillary ultrasound in the pre-operative assessment of breast cancer patients? Eur Radiol. 2015;25:2682\u20137.","journal-title":"Eur Radiol"},{"key":"1582_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejso.2015.01.011","volume":"41","author":"MR Boland","year":"2015","unstructured":"Boland MR, Prichard RS, Daskalova I, Lowery AJ, Evoy D, Geraghty J, Rothwell J, Quinn CM, O'Doherty A, McDermott EW. Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011. Eur J Surg Oncol. 2015;41:559\u201365.","journal-title":"Eur J Surg Oncol"},{"key":"1582_CR20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.surg.2013.07.017","volume":"154","author":"TJ Hieken","year":"2013","unstructured":"Hieken TJ, Trull BC, Boughey JC, Jones KN, Reynolds CA, Shah SS, Glazebrook KN. Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer. Surgery. 2013;154:831\u20138 discussion 8-40.","journal-title":"Surgery."},{"key":"1582_CR21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/s10434-015-4944-y","volume":"23","author":"M Pilewskie","year":"2016","unstructured":"Pilewskie M, Mautner SK, Stempel M, Eaton A, Morrow M. Does a positive axillary lymph node needle biopsy result predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era? Ann Surg Oncol. 2016;23:1123\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1582_CR22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4048\/jbc.2017.20.3.270","volume":"20","author":"I Kim","year":"2017","unstructured":"Kim I, Ryu JM, Kim JM, Choi HJ, Lee SK, Yu JH, Lee JE, Kim SW, Nam SJ. Development of a nomogram to predict N2 or N3 stage in T1-2 invasive breast cancer patients with no palpable lymphadenopathy. J Breast Cancer. 2017;20:270\u20138.","journal-title":"J Breast Cancer"},{"key":"1582_CR23","doi-asserted-by":"crossref","first-page":"e3689","DOI":"10.1097\/MD.0000000000003689","volume":"95","author":"MJ Chung","year":"2016","unstructured":"Chung MJ, Lee JH, Kim SH, Suh YJ, Choi HJ. Simple prediction model of axillary lymph node positivity after analyzing molecular and clinical factors in early breast cancer. Medicine (Baltimore). 2016;95:e3689.","journal-title":"Medicine (Baltimore)"},{"key":"1582_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1590\/0100-69912017004014","volume":"44","author":"OFN Costa","year":"2017","unstructured":"Costa OFN, Castro RB, Oliveira CV, Feitosa TVN, Alves JJJ, Cavalcante FP, Lima MVA. Predictive factors of axillary metastasis in patients with breast cancer and positive sentinel lymph node biopsy. Revista do Colegio Brasileiro de Cirurgioes. 2017;44:391\u20136.","journal-title":"Revista do Colegio Brasileiro de Cirurgioes"},{"key":"1582_CR25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/jnci\/86.23.1771","volume":"86","author":"PM Ravdin","year":"1994","unstructured":"Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst. 1994;86:1771\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"1582_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CBC.2008.n.028","volume":"8","author":"SJ Crabb","year":"2008","unstructured":"Crabb SJ, Cheang MC, Leung S, Immonen T, Nielsen TO, Huntsman DD, Bajdik CD, Chia SK. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer. 2008;8:249\u201356.","journal-title":"Clin Breast Cancer"},{"key":"1582_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10549-016-3755-6","volume":"156","author":"GM Kramer","year":"2016","unstructured":"Kramer GM, Leenders MW, Schijf LJ, Go HL, van der Ploeg T, van den Tol MP, Schreurs WH. Is ultrasound-guided fine-needle aspiration cytology of adequate value in detecting breast cancer patients with three or more positive axillary lymph nodes? Breast Cancer Res Treat. 2016;156:271\u20138.","journal-title":"Breast Cancer Res Treat"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1582-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-019-1582-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1582-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T19:11:56Z","timestamp":1582139516000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-019-1582-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1186\/s12957-019-1582-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"1 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The independent Ethical Committee\/Institutional Review Board of Ruijin Hospital, Shanghai Jiaotong University School of Medicine reviewed and approved this study protocol, which was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"37"}}